BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17541741)

  • 1. Tamoxifen, hot flashes and recurrence in breast cancer.
    Mortimer JE; Flatt SW; Parker BA; Gold EB; Wasserman L; Natarajan L; Pierce JP;
    Breast Cancer Res Treat; 2008 Apr; 108(3):421-6. PubMed ID: 17541741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer.
    Pandya KJ; Thummala AR; Griggs JJ; Rosenblatt JD; Sahasrabudhe DM; Guttuso TJ; Morrow GR; Roscoe JA
    Breast Cancer Res Treat; 2004 Jan; 83(1):87-9. PubMed ID: 14997058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis.
    Bardia A; Novotny P; Sloan J; Barton D; Loprinzi C
    Menopause; 2009; 16(3):477-83. PubMed ID: 19188850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.
    Rohatgi N; Blau R; Lower EE
    J Womens Health Gend Based Med; 2002 Apr; 11(3):291-301. PubMed ID: 11988138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.
    Cuzick J; Sestak I; Cella D; Fallowfield L;
    Lancet Oncol; 2008 Dec; 9(12):1143-8. PubMed ID: 18976959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
    Dezentjé VO; Gelderblom H; Van Schaik RH; Vletter-Bogaartz JM; Van der Straaten T; Wessels JA; Kranenbarg EM; Berns EM; Seynaeve C; Putter H; Van de Velde CJ; Nortier JW; Guchelaar HJ
    Breast Cancer Res Treat; 2014 Jan; 143(1):171-9. PubMed ID: 24265036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.
    Henry NL; Rae JM; Li L; Azzouz F; Skaar TC; Desta Z; Sikora MJ; Philips S; Nguyen AT; Storniolo AM; Hayes DF; Flockhart DA; Stearns V;
    Breast Cancer Res Treat; 2009 Oct; 117(3):571-5. PubMed ID: 19153830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial.
    Hervik J; Mjåland O
    Breast Cancer Res Treat; 2009 Jul; 116(2):311-6. PubMed ID: 18839306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
    Pandya KJ; Raubertas RF; Flynn PJ; Hynes HE; Rosenbluth RJ; Kirshner JJ; Pierce HI; Dragalin V; Morrow GR
    Ann Intern Med; 2000 May; 132(10):788-93. PubMed ID: 10819701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of shugan liangxue compound for relieving hot flashes in breast cancer patients].
    Sun H; Xue D; Gao F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):30-3. PubMed ID: 19338149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Acupuncture on Hot Flashes in Breast Cancer Patients Receiving Adjuvant Antiestrogen Therapy with Tamoxifen: A Randomized Controlled Trial.
    Jeong YJ; Choi HR; Kim KS; Shin IH; Park SH
    J Integr Complement Med; 2023 Apr; 29(4):241-252. PubMed ID: 36787483
    [No Abstract]   [Full Text] [Related]  

  • 14. Tamoxifen-induced hot flashes.
    Loprinzi CL; Zahasky KM; Sloan JA; Novotny PJ; Quella SK
    Clin Breast Cancer; 2000 Apr; 1(1):52-6. PubMed ID: 11899390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hot flash on tamoxifen metabolism.
    Goetz MP; Loprinzi CL
    J Natl Cancer Inst; 2003 Dec; 95(23):1734-5. PubMed ID: 14652227
    [No Abstract]   [Full Text] [Related]  

  • 16. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
    Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
    Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
    Baum M; Buzdar A; Cuzick J; Forbes J; Houghton J; Howell A; Sahmoud T;
    Cancer; 2003 Nov; 98(9):1802-10. PubMed ID: 14584060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial.
    Hale MJ; Howell A; Dowsett M; Cuzick J; Sestak I
    Breast; 2020 Dec; 54():216-221. PubMed ID: 33160147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using traditional acupuncture for breast cancer-related hot flashes and night sweats.
    de Valois BA; Young TE; Robinson N; McCourt C; Maher EJ
    J Altern Complement Med; 2010 Oct; 16(10):1047-57. PubMed ID: 20954961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22.
    Baxter SD; Teft WA; Choi YH; Winquist E; Kim RB
    Breast Cancer Res Treat; 2014 Jun; 145(2):419-28. PubMed ID: 24744093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.